Clinical Cancer Research: 12 (20)

Editorial

Editorial

Can a Single Pill Replace Doublet Chemotherapy in First-Line Therapy of Advanced Non–Small Cell Lung Cancer?

Paul A. Bunn Jr.

Clin Cancer Res October 15 2006 12 (20) 5919-5920; DOI:10.1158/1078-0432.CCR-06-1553

The Biology Behind

The Biology Behind

Natural Killer T Cell–Based Cancer Immunotherapy

Hans J.J. van der Vliet, Steven P. Balk and Mark A. Exley

Clin Cancer Res October 15 2006 12 (20) 5921-5923; DOI:10.1158/1078-0432.CCR-06-1392

Molecular Pathways

Molecular Pathways

The Hedgehog Signaling Pathway in Cancer

Marie Evangelista, Hua Tian and Frederic J. de Sauvage

Clin Cancer Res October 15 2006 12 (20) 5924-5928; DOI:10.1158/1078-0432.CCR-06-1736

Special Article

Special Article

The FLIP-Side of Fas Signaling

Marc L. Hyer, Temesgen Samuel and John C. Reed

Clin Cancer Res October 15 2006 12 (20) 5929-5931; DOI:10.1158/1078-0432.CCR-06-2098

Human Cancer Biology

Human Cancer Biology

PIK3CA and PTEN Mutations in Uterine Endometrioid Carcinoma and Complex Atypical Hyperplasia

Monica Prasad Hayes, Hong Wang, Rosanny Espinal-Witter, Wayne Douglas, Garron J. Solomon, Suzanne J. Baker and Lora Hedrick Ellenson

Clin Cancer Res October 15 2006 12 (20) 5932-5935; DOI:10.1158/1078-0432.CCR-06-1375
Human Cancer Biology

Met Receptor Signaling: A Key Effector in Esophageal Adenocarcinoma

Mark R. Anderson, Rebecca Harrison, Paul A. Atherfold, Moray J. Campbell, S. Jane Darnton, Jolanta Obszynska and Janusz A.Z Jankowski

Clin Cancer Res October 15 2006 12 (20) 5936-5943; DOI:10.1158/1078-0432.CCR-06-1208
Human Cancer Biology

Gene Expression Signatures Differentiate Ovarian/Peritoneal Serous Carcinoma from Diffuse Malignant Peritoneal Mesothelioma

Ben Davidson, Zhen Zhang, Lilach Kleinberg, Mei Li, Vivi Ann Flørenes, Tian-Li Wang and Ie-Ming Shih

Clin Cancer Res October 15 2006 12 (20) 5944-5950; DOI:10.1158/1078-0432.CCR-06-1059
Human Cancer Biology

GROα Is Highly Expressed in Adenocarcinoma of the Colon and Down-Regulates Fibulin-1

Yu Wen, Sarah F. Giardina, David Hamming, Jennifer Greenman, Emmanuel Zachariah, Manny D. Bacolod, Hao Liu, Jinru Shia, Peter S. Amenta, Francis Barany, Phillip Paty, William Gerald and Daniel Notterman

Clin Cancer Res October 15 2006 12 (20) 5951-5959; DOI:10.1158/1078-0432.CCR-06-0736
Human Cancer Biology

Identification of a Gene Signature for Rapid Screening of Oral Squamous Cell Carcinoma

Amy F. Ziober, Kirtesh R. Patel, Faizan Alawi, Phyllis Gimotty, Randall S. Weber, Michael M. Feldman, Ara A. Chalian, Gregory S. Weinstein, Jennifer Hunt and Barry L. Ziober

Clin Cancer Res October 15 2006 12 (20) 5960-5971; DOI:10.1158/1078-0432.CCR-06-0535
Human Cancer Biology

Carcinoembryonic Antigen Messenger RNA Expression in Blood Predicts Recurrence in Esophageal Cancer

Tetsuro Setoyama, Shoji Natsugoe, Hiroshi Okumura, Masataka Matsumoto, Yasuto Uchikado, Sumiya Ishigami, Tetsuhiro Owaki, Sonshin Takao and Takashi Aikou

Clin Cancer Res October 15 2006 12 (20) 5972-5977; DOI:10.1158/1078-0432.CCR-06-0637
Human Cancer Biology

The Potential of BORIS Detected in the Leukocytes of Breast Cancer Patients as an Early Marker of Tumorigenesis

Vivien D'Arcy, Ziedulla K. Abdullaev, Naresh Pore, France Docquier, Verónica Torrano, Igor Chernukhin, Melissa Smart, Dawn Farrar, Metodi Metodiev, Nelson Fernandez, Carlos Richard, M. Dolores Delgado, Victor Lobanenkov and Elena Klenova

Clin Cancer Res October 15 2006 12 (20) 5978-5986; DOI:10.1158/1078-0432.CCR-05-2731
Human Cancer Biology

Expression of Stress Response Protein Grp78 Is Associated with the Development of Castration-Resistant Prostate Cancer

Llana Pootrakul, Ram H. Datar, Shan-Rong Shi, Jie Cai, Debra Hawes, Susan G. Groshen, Amy S. Lee and Richard J. Cote

Clin Cancer Res October 15 2006 12 (20) 5987-5993; DOI:10.1158/1078-0432.CCR-06-0133
Human Cancer Biology

Biological Role of Estrogen Receptor β in Salivary Gland Adenocarcinoma Cells

Kazufumi Ohshiro, Suresh K. Rayala, Michelle D. Williams, Rakesh Kumar and Adel K. El-Naggar

Clin Cancer Res October 15 2006 12 (20) 5994-5999; DOI:10.1158/1078-0432.CCR-06-1251
Human Cancer Biology

The Novel p21 Polymorphism p21^G251A Is Associated with Locally Advanced Breast Cancer

Vidar Staalesen, Stian Knappskog, Ranjan Chrisanthar, Silje H. Nordgard, Erik Løkkevik, Gun Anker, Bjørn Østenstad, Steinar Lundgren, Terje Risberg, Ingvil Mjaaland, Inger Torhild Gram, Vessela N. Kristensen, Anne-Lise Børresen-Dale, Johan Richard Lillehaug and Per Eystein Lønning

Clin Cancer Res October 15 2006 12 (20) 6000-6004; DOI:10.1158/1078-0432.CCR-05-2822
Human Cancer Biology

A Homeobox Protein, Prox1, Is Involved in the Differentiation, Proliferation, and Prognosis in Hepatocellular Carcinoma

Masayuki Shimoda, Meiko Takahashi, Takanobu Yoshimoto, Tomoya Kono, Iwao Ikai and Hajime Kubo

Clin Cancer Res October 15 2006 12 (20) 6005-6011; DOI:10.1158/1078-0432.CCR-06-0712
Human Cancer Biology

Glucocorticoids Suppress Tumor Lymphangiogenesis of Prostate Cancer Cells

Akihiro Yano, Yasuhisa Fujii, Aki Iwai, Satoru Kawakami, Yukio Kageyama and Kazunori Kihara

Clin Cancer Res October 15 2006 12 (20) 6012-6017; DOI:10.1158/1078-0432.CCR-06-0749

Imaging, Diagnosis, Prognosis

Imaging, Diagnosis, Prognosis

Prognostic Value of Prostate Secretory Protein of 94 Amino Acids and its Binding Protein after Radical Prostatectomy

Jonathan R. Reeves, Hélène Dulude, Chandra Panchal, Luc Daigneault and Dharam M. Ramnani

Clin Cancer Res October 15 2006 12 (20) 6018-6022; DOI:10.1158/1078-0432.CCR-06-0625
Imaging, Diagnosis, Prognosis

Reverse Transcription-PCR for t(11;18)(q21;q21) Staging and Monitoring in Mucosa-Associated Lymphoid Tissue Lymphoma

Berthold Streubel, Daniela Huber, Stefan Wöhrer, Andreas Chott and Markus Raderer

Clin Cancer Res October 15 2006 12 (20) 6023-6028; DOI:10.1158/1078-0432.CCR-06-0232
Imaging, Diagnosis, Prognosis

The p53 Pathway and Outcome among Patients with T1G3 Bladder Tumors

Elena López-Knowles, Silvia Hernández, Manolis Kogevinas, Josep Lloreta, Alex Amorós, Adonina Tardón, Alfredo Carrato, Sirish Kishore, Consol Serra, Núria Malats and Francisco X. Real

Clin Cancer Res October 15 2006 12 (20) 6029-6036; DOI:10.1158/1078-0432.CCR-06-0206
Imaging, Diagnosis, Prognosis

Functional Plasminogen Activator Inhibitor-1 Gene Variants and Breast Cancer Survival

Xianglan Zhang, Xiao-Ou Shu, Qiuyin Cai, ZhiXian Ruan, Yu-Tang Gao and Wei Zheng

Clin Cancer Res October 15 2006 12 (20) 6037-6042; DOI:10.1158/1078-0432.CCR-05-2851
Imaging, Diagnosis, Prognosis

Hepatoma-Derived Growth Factor Is a Novel Prognostic Factor for Patients with Pancreatic Cancer

Hirokazu Uyama, Yasuhiko Tomita, Hideji Nakamura, Shoji Nakamori, Binglin Zhang, Yoshihiko Hoshida, Hirayuki Enomoto, Yorihide Okuda, Masato Sakon, Katsuyuki Aozasa, Ichiro Kawase, Norio Hayashi and Morito Monden

Clin Cancer Res October 15 2006 12 (20) 6043-6048; DOI:10.1158/1078-0432.CCR-06-1064

Cancer Therapy: Clinical

Cancer Therapy: Clinical

Erlotinib for Frontline Treatment of Advanced Non–Small Cell Lung Cancer: a Phase II Study

Giuseppe Giaccone, Marielle Gallegos Ruiz, Thierry Le Chevalier, Nick Thatcher, Egbert Smit, Jose Antonio Rodriguez, Pasi Janne, Dalila Oulid-Aissa and Jean-Charles Soria

Clin Cancer Res October 15 2006 12 (20) 6049-6055; DOI:10.1158/1078-0432.CCR-06-0260
Cancer Therapy: Clinical

Randomized Phase II Study of Interleukin-12 in Combination with Rituximab in Previously Treated Non-Hodgkin's Lymphoma Patients

Stephen M. Ansell, Susan M. Geyer, Matthew J. Maurer, Paul J. Kurtin, Ivana N.M. Micallef, Philip Stella, Paul Etzell, Anne J. Novak, Charles Erlichman and Thomas E. Witzig

Clin Cancer Res October 15 2006 12 (20) 6056-6063; DOI:10.1158/1078-0432.CCR-06-1245
Cancer Therapy: Clinical

A Phase I Dose Escalation Study with Anti-CD44v6 Bivatuzumab Mertansine in Patients with Incurable Squamous Cell Carcinoma of the Head and Neck or Esophagus

Bernard M. Tijink, Jan Buter, Remco de Bree, Giuseppe Giaccone, Margreet S. Lang, Alexander Staab, C. René Leemans and Guus A.M.S. van Dongen

Clin Cancer Res October 15 2006 12 (20) 6064-6072; DOI:10.1158/1078-0432.CCR-06-0910
Cancer Therapy: Clinical

Pharmacokinetic-Pharmacodynamic Relationships of Imatinib and Its Main Metabolite in Patients with Advanced Gastrointestinal Stromal Tumors

Catherine Delbaldo, Etienne Chatelut, Micheline Ré, Alain Deroussent, Sophie Séronie-Vivien, Aurore Jambu, Patrice Berthaud, Axel Le Cesne, Jean-Yves Blay and Gilles Vassal

Clin Cancer Res October 15 2006 12 (20) 6073-6078; DOI:10.1158/1078-0432.CCR-05-2596
Cancer Therapy: Clinical

A Phase I Study of In vitro Expanded Natural Killer T Cells in Patients with Advanced and Recurrent Non–Small Cell Lung Cancer

Shinichiro Motohashi, Aki Ishikawa, Eiichi Ishikawa, Mizuto Otsuji, Toshihiko Iizasa, Hideki Hanaoka, Naomi Shimizu, Shigetoshi Horiguchi, Yoshitaka Okamoto, Shin-ichiro Fujii, Masaru Taniguchi, Takehiko Fujisawa and Toshinori Nakayama

Clin Cancer Res October 15 2006 12 (20) 6079-6086; DOI:10.1158/1078-0432.CCR-06-0114
Cancer Therapy: Clinical

A Phase I Trial of Twice-Weekly 17-Allylamino-Demethoxy-Geldanamycin in Patients with Advanced Cancer

Grzegorz S. Nowakowski, Andrea K. McCollum, Matthew M. Ames, Sumithra J. Mandrekar, Joel M. Reid, Alex A. Adjei, David O. Toft, Stephanie L. Safgren and Charles Erlichman

Clin Cancer Res October 15 2006 12 (20) 6087-6093; DOI:10.1158/1078-0432.CCR-06-1015
Cancer Therapy: Clinical

Hoosier Oncology Group Randomized Phase II Study of Docetaxel, Vinorelbine, and Estramustine in Combination in Hormone-Refractory Prostate Cancer with Pharmacogenetic Survival Analysis

Noah M. Hahn, Sharon Marsh, William Fisher, Robert Langdon, Robin Zon, Mark Browning, Cynthia S. Johnson, Tiffany J. Scott-Horton, Lang Li, Howard L. McLeod and Christopher J. Sweeney

Clin Cancer Res October 15 2006 12 (20) 6094-6099; DOI:10.1158/1078-0432.CCR-06-1188
Cancer Therapy: Clinical

Pharmacokinetics and Toxicity of Weekly Docetaxel in Older Patients

Arti Hurria, Mark T. Fleming, Sharyn D. Baker, Wm. Kevin Kelly, Katie Cutchall, Katherine Panageas, James Caravelli, Henry Yeung, Mark G. Kris, Jorge Gomez, Vincent A. Miller, Gabriella D'Andrea, Howard I. Scher, Larry Norton and Clifford Hudis

Clin Cancer Res October 15 2006 12 (20) 6100-6105; DOI:10.1158/1078-0432.CCR-06-0200
Cancer Therapy: Clinical

A Phase I Study on Adoptive Immunotherapy Using Gene-Modified T Cells for Ovarian Cancer

Michael H. Kershaw, Jennifer A. Westwood, Linda L. Parker, Gang Wang, Zelig Eshhar, Sharon A. Mavroukakis, Donald E. White, John R. Wunderlich, Silvana Canevari, Linda Rogers-Freezer, Clara C. Chen, James C. Yang, Steven A. Rosenberg and Patrick Hwu

Clin Cancer Res October 15 2006 12 (20) 6106-6115; DOI:10.1158/1078-0432.CCR-06-1183
Cancer Therapy: Clinical

Bcl-2 Expression as a Predictive Marker of Hormone-Refractory Prostate Cancer Treated with Taxane-Based Chemotherapy

Tateki Yoshino, Hiroaki Shiina, Shinji Urakami, Nobuyuki Kikuno, Tatsuaki Yoneda, Kazushi Shigeno and Mikio Igawa

Clin Cancer Res October 15 2006 12 (20) 6116-6124; DOI:10.1158/1078-0432.CCR-06-0147

Cancer Therapy: Preclinical

Cancer Therapy: Preclinical

Multidrug Resistance Protein 2 Is an Important Determinant of Paclitaxel Pharmacokinetics

Jurjen S. Lagas, Maria L. Vlaming, Olaf van Tellingen, Els Wagenaar, Robert S. Jansen, Hilde Rosing, Jos H. Beijnen and Alfred H. Schinkel

Clin Cancer Res October 15 2006 12 (20) 6125-6132; DOI:10.1158/1078-0432.CCR-06-1352
Cancer Therapy: Preclinical

Piroxicam and Cisplatin in a Mouse Model of Peritoneal Mesothelioma

Enrico P. Spugnini, Irene Cardillo, Alessandra Verdina, Stefania Crispi, Silvia Saviozzi, Raffaele Calogero, Angela Nebbioso, Lucia Altucci, Giancarlo Cortese, Rossella Galati, Jeremy Chien, Viji Shridhar, Bruno Vincenzi, Gennaro Citro, Francesco Cognetti, Ada Sacchi and Alfonso Baldi

Clin Cancer Res October 15 2006 12 (20) 6133-6143; DOI:10.1158/1078-0432.CCR-06-1056
Cancer Therapy: Preclinical

A Novel One-Armed Anti-c-Met Antibody Inhibits Glioblastoma Growth In vivo

Tobias Martens, Nils-Ole Schmidt, Carmen Eckerich, Regina Fillbrandt, Mark Merchant, Ralph Schwall, Manfred Westphal and Katrin Lamszus

Clin Cancer Res October 15 2006 12 (20) 6144-6152; DOI:10.1158/1078-0432.CCR-05-1418
Cancer Therapy: Preclinical

Combined In vivo Effect of A12, a Type 1 Insulin-Like Growth Factor Receptor Antibody, and Docetaxel against Prostate Cancer Tumors

Jennifer D. Wu, Kathy Haugk, Ilsa Coleman, Lillie Woodke, Robert Vessella, Peter Nelson, R. Bruce Montgomery, Dale L. Ludwig and Stephen R. Plymate

Clin Cancer Res October 15 2006 12 (20) 6153-6160; DOI:10.1158/1078-0432.CCR-06-0443
Cancer Therapy: Preclinical

Effect of Simultaneous Inhibition of Epidermal Growth Factor Receptor and Cyclooxygenase-2 in HER-2/Neu-Positive Breast Cancer

Susan Lanza-Jacoby, Randy Burd, Francis E. Rosato Jr., Kandace McGuire, James Little, Noel Nougbilly and Sheldon Miller

Clin Cancer Res October 15 2006 12 (20) 6161-6169; DOI:10.1158/1078-0432.CCR-06-0042
Cancer Therapy: Preclinical

The Use of a Tropism-Modified Measles Virus in Folate Receptor–Targeted Virotherapy of Ovarian Cancer

Kosei Hasegawa, Takafumi Nakamura, Mary Harvey, Yasuhiro Ikeda, Ann Oberg, Mariangela Figini, Silvana Canevari, Lynn C. Hartmann and Kah-Whye Peng

Clin Cancer Res October 15 2006 12 (20) 6170-6178; DOI:10.1158/1078-0432.CCR-06-0992
Cancer Therapy: Preclinical

Gene Therapy Using Adenovirus-Mediated Full-length Anti-HER-2 Antibody for HER-2 Overexpression Cancers

Minghong Jiang, Wenfang Shi, Qi Zhang, Xinhua Wang, Minggao Guo, Zhenfu Cui, Changqin Su, Qing Yang, Yuemin Li, Jonathan Sham, Xinyuan Liu, Mengchao Wu and Qijun Qian

Clin Cancer Res October 15 2006 12 (20) 6179-6185; DOI:10.1158/1078-0432.CCR-06-0746
Cancer Therapy: Preclinical

Preclinical Antitumor Activity of BMS-599626, a pan-HER Kinase Inhibitor That Inhibits HER1/HER2 Homodimer and Heterodimer Signaling

Tai W. Wong, Francis Y. Lee, Chiang Yu, Feng R. Luo, Simone Oppenheimer, Hongjian Zhang, Richard A. Smykla, Harold Mastalerz, Brian E. Fink, John T. Hunt, Ashvinikumar V. Gavai and Gregory D. Vite

Clin Cancer Res October 15 2006 12 (20) 6186-6193; DOI:10.1158/1078-0432.CCR-06-0642

Cancer Susceptibility and Prevention

Cancer Susceptibility and Prevention

Grape Seed Extract Inhibits In vitro and In vivo Growth of Human Colorectal Carcinoma Cells

Manjinder Kaur, Rana P. Singh, Mallikarjuna Gu, Rajesh Agarwal and Chapla Agarwal

Clin Cancer Res October 15 2006 12 (20) 6194-6202; DOI:10.1158/1078-0432.CCR-06-1465

Letters to the Editor

Letters to the Editor

The Activity of Sunitinib against Gastrointestinal Stromal Tumor Seems to be Distinct from Its Antiangiogenic Effects

Marco Seandel, Jinru Shia, Irina Linkov, Robert G. Maki, Cristina R. Antonescu and Jakob Dupont

Clin Cancer Res October 15 2006 12 (20) 6203-6204; DOI:10.1158/1078-0432.CCR-06-1292
Letters to the Editor

Does MDR-1 G2677T/A Polymorphism Really Associate with Ovarian Cancer Response to Paclitaxel Chemotherapy?

Agnieszka H. Ludwig and Jolanta Kupryjañczyk

Clin Cancer Res October 15 2006 12 (20) 6204-6204; DOI:10.1158/1078-0432.CCR-06-1374
Letters to the Editor

Polyclonal Resistance in Gastrointestinal Stromal Tumor Treated with Sequential Kinase Inhibitors

Maurice B. Loughrey, Paul M. Waring, Alex Dobrovic, George Demetri, Serge Kovalenko and Grant McArthur

Clin Cancer Res October 15 2006 12 (20) 6205-6206; DOI:10.1158/1078-0432.CCR-06-1079
Letters to the Editor

Polyclonal Resistance in Gastrointestinal Stromal Tumor Treated with Sequential Kinase Inhibitors

Eva Wardelmann, Katharina Biermann, Sabine Merkelbach-Bruse, Hans-Ulrich Schildhaus, Nadja Thomas, Reinhard Büttner, Torsten Pietsch, Thomas Heinicke, Nicola Speidel, Daniel Pink, Peter Reichardt and Peter Hohenberger

Clin Cancer Res October 15 2006 12 (20) 6206-6206; DOI:10.1158/1078-0432.CCR-06-1749

Advances in Treating Metastatic Bone Cancer

Advances in Treating Metastatic Bone Cancer

Advances in Treating Metastatic Bone Cancer: Summary Statement for the First Cambridge Conference

Allan Lipton, James R. Berenson, Jean-Jacques Body, Brendan F. Boyce, Oyvind S. Bruland, Michael A. Carducci, Charles S. Cleeland, Denis R. Clohisy, Robert E. Coleman, Richard J. Cook, Theresa A. Guise, Roger N. Pearse, Trevor J. Powles, Michael J. Rogers, G. David Roodman, Matthew R. Smith, Larry J. Suva, Robert L. Vessella, Katherine N. Weilbaecher and Laura King

Clin Cancer Res October 15 2006 12 (20) 6209s-6212s; DOI:10.1158/1078-0432.CCR-06-1213
Advances in Treating Metastatic Bone Cancer

Basic Mechanisms Responsible for Osteolytic and Osteoblastic Bone Metastases

Theresa A. Guise, Khalid S. Mohammad, Gregory Clines, Elizabeth G. Stebbins, Darren H. Wong, Linda S. Higgins, Robert Vessella, Eva Corey, Susan Padalecki, Larry Suva and John M. Chirgwin

Clin Cancer Res October 15 2006 12 (20) 6213s-6216s; DOI:10.1158/1078-0432.CCR-06-1007
Advances in Treating Metastatic Bone Cancer

Genomics and Proteomics of Bone Cancer

Aaron G. Marguiles, V. Suzanne Klimberg, Sudeepa Bhattacharrya, Dana Gaddy and Larry J. Suva

Clin Cancer Res October 15 2006 12 (20) 6217s-6221s; DOI:10.1158/1078-0432.CCR-06-1070
Advances in Treating Metastatic Bone Cancer

Molecular Mechanisms of Action of Bisphosphonates: Current Status

Anke J. Roelofs, Keith Thompson, Sharon Gordon and Michael J. Rogers

Clin Cancer Res October 15 2006 12 (20) 6222s-6230s; DOI:10.1158/1078-0432.CCR-06-0843
Advances in Treating Metastatic Bone Cancer

Biology of Bone Cancer Pain

Michael J. Goblirsch, Pawel P. Zwolak and Denis R. Clohisy

Clin Cancer Res October 15 2006 12 (20) 6231s-6235s; DOI:10.1158/1078-0432.CCR-06-0682
Advances in Treating Metastatic Bone Cancer

The Measurement of Pain from Metastatic Bone Disease: Capturing the Patient's Experience

Charles S. Cleeland

Clin Cancer Res October 15 2006 12 (20) 6236s-6242s; DOI:10.1158/1078-0432.CCR-06-0988
Advances in Treating Metastatic Bone Cancer

Clinical Features of Metastatic Bone Disease and Risk of Skeletal Morbidity

Robert E. Coleman

Clin Cancer Res October 15 2006 12 (20) 6243s-6249s; DOI:10.1158/1078-0432.CCR-06-0931
Advances in Treating Metastatic Bone Cancer

High-Linear Energy Transfer Irradiation Targeted to Skeletal Metastases by the α-Emitter ²²³Ra: Adjuvant or Alternative to Conventional Modalities?

Øyvind S. Bruland, Sten Nilsson, Darrell R. Fisher and Roy H. Larsen

Clin Cancer Res October 15 2006 12 (20) 6250s-6257s; DOI:10.1158/1078-0432.CCR-06-0841
Advances in Treating Metastatic Bone Cancer

Breast Cancer: Bisphosphonate Therapy for Metastatic Bone Disease

Jean-Jacques Body

Clin Cancer Res October 15 2006 12 (20) 6258s-6263s; DOI:10.1158/1078-0432.CCR-06-0840
Advances in Treating Metastatic Bone Cancer

Multistate Analysis of Skeletal Events in Patients with Bone Metastases

Richard J. Cook and Pierre Major

Clin Cancer Res October 15 2006 12 (20) 6264s-6269s; DOI:10.1158/1078-0432.CCR-06-0654
Advances in Treating Metastatic Bone Cancer

New Potential Targets for Treating Myeloma Bone Disease

G. David Roodman

Clin Cancer Res October 15 2006 12 (20) 6270s-6273s; DOI:10.1158/1078-0432.CCR-06-0845
Advances in Treating Metastatic Bone Cancer

Wnt Antagonism in Multiple Myeloma: A Potential Cause of Uncoupled Bone Remodeling

Roger N. Pearse

Clin Cancer Res October 15 2006 12 (20) 6274s-6278s; DOI:10.1158/1078-0432.CCR-06-0648
Advances in Treating Metastatic Bone Cancer

Treatment for Myeloma Bone Disease

Howard S. Yeh and James R. Berenson

Clin Cancer Res October 15 2006 12 (20) 6279s-6284s; DOI:10.1158/1078-0432.CCR-06-0681
Advances in Treating Metastatic Bone Cancer

Targeting Factors Involved in Bone Remodeling as Treatment Strategies in Prostate Cancer Bone Metastasis

Robert L. Vessella and Eva Corey

Clin Cancer Res October 15 2006 12 (20) 6285s-6290s; DOI:10.1158/1078-0432.CCR-06-0813
Advances in Treating Metastatic Bone Cancer

Src Inhibitors in Metastatic Bone Disease

Brendan F. Boyce, Lianping Xing, Zhenqiang Yao, Teruhito Yamashita, William C. Shakespeare, Yihan Wang, Chester A. Metcalf III, Raji Sundaramoorthi, David C. Dalgarno, John D. Iuliucci and Tomi K. Sawyer

Clin Cancer Res October 15 2006 12 (20) 6291s-6295s; DOI:10.1158/1078-0432.CCR-06-0991
Advances in Treating Metastatic Bone Cancer

Targeting Bone Metastasis in Prostate Cancer with Endothelin Receptor Antagonists

Michael A. Carducci and Antonio Jimeno

Clin Cancer Res October 15 2006 12 (20) 6296s-6300s; DOI:10.1158/1078-0432.CCR-06-0929
Advances in Treating Metastatic Bone Cancer

Oral Bisphosphonates as Adjuvant Therapy for Operable Breast Cancer

Trevor Powles, Eugene McCroskey and Alexander Paterson

Clin Cancer Res October 15 2006 12 (20) 6301s-6304s; DOI:10.1158/1078-0432.CCR-06-1211
Advances in Treating Metastatic Bone Cancer

Future Treatment of Bone Metastases

Allan Lipton

Clin Cancer Res October 15 2006 12 (20) 6305s-6308s; DOI:10.1158/1078-0432.CCR-06-1157
Advances in Treating Metastatic Bone Cancer

Skeletal Complications of Breast Cancer Therapies

Angela Hirbe, Elizabeth A. Morgan, Özge Uluçkan and Katherine Weilbaecher

Clin Cancer Res October 15 2006 12 (20) 6309s-6314s; DOI:10.1158/1078-0432.CCR-06-0652
Advances in Treating Metastatic Bone Cancer

Treatment-Related Osteoporosis in Men with Prostate Cancer

Matthew R. Smith

Clin Cancer Res October 15 2006 12 (20) 6315s-6319s; DOI:10.1158/1078-0432.CCR-06-0846

Main menu

User menu

Search

Table of Contents

Editorial

The Biology Behind

Molecular Pathways

Special Article

Human Cancer Biology

Imaging, Diagnosis, Prognosis

Cancer Therapy: Clinical

Cancer Therapy: Preclinical

Cancer Susceptibility and Prevention

Letters to the Editor

Advances in Treating Metastatic Bone Cancer

Issue Highlights

Jump to

Articles

Info for

About Clinical Cancer Research